Lamisil

Terbinafine Hydrochloride, the active ingredient in Lamisil, is an antifungal presented as a topical formulation for skin use. It treats dermatophyte infections such as athlete’s foot, ringworm, jock itch, and fungal nail disease in both adults and children, helping to clear lesions and relieve associated symptoms.

GNH USA supplies Lamisil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution aligned to EU market standards. The product meets stringent quality controls and is manufactured under GMP conditions.

Lamisil is an antifungal agent indicated for dermatophyte infections of the skin and nails.

- Tinea pedis: clears athlete’s foot infection and reduces itching and scaling. - Tinea corporis: resolves ringworm lesions on the body. - Tinea cruris: treats jock itch, alleviating redness and discomfort. - Onychomycosis: improves fungal nail involvement, promoting clearer nail appearance.

Topical terbinafine may cause local and, rarely, systemic adverse reactions.

Common Side Effects: - Skin irritation: mild burning or stinging at application site. - Redness: localized erythema. - Itching: pruritus around treated area. - Dryness: skin peeling or flaking.

Serious or Rare Side Effects: - Severe allergic reaction: angioedema or anaphylaxis. - Contact dermatitis: intense rash with swelling. - Stevens‑Johnson syndrome: blistering skin eruption. - Hepatic dysfunction: elevated liver enzymes (rare systemic absorption).

Before using Lamisil, consider the following precautions to ensure safe and effective treatment.

- Assess hypersensitivity: confirm no known allergy to terbinafine or cream excipients. - Avoid broken skin: do not apply on open wounds or extensive erosions. - Limit surface area: restrict use to less than 20% of body surface at a time. - Caution in hepatic impairment: use with medical supervision if liver disease is present. - Pregnancy and lactation: discuss risks with a healthcare professional before use. - Store at room temperature: keep in original container, protect from moisture and heat.

Terbinafine may interact with other medicines, especially when systemic exposure occurs.

Major Interactions (Avoid): - Strong CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may increase systemic terbinafine levels if absorbed. - Concurrent topical azole antifungals: can antagonize terbinafine’s activity. - Occlusive dressings: may enhance percutaneous absorption leading to higher systemic exposure.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may mask irritation signs, requiring monitoring. - Alcohol‑based skin cleansers: can increase local irritation when used before application. - Systemic antifungals (itraconazole, ketoconazole): combined use may increase risk of liver toxicity.